Albius Animal Health
Our R&D Strategy for Coronavirus
Coronavirus first appeared about 10,000 years before 2019.
It can cause infections in a variety of animals, including:
Humans | Cats | Dogs | Pigs | Horses
Cows | Chickens | Camels | Whales
All these coronaviruses share the same or similar characteristics and lineage as the prevalent COVID-19.
So by logical deduction and in theory, the antiviral drugs effective against COVID-19 would also be applicable to all other coronaviruses.
Albius’ anti-CoV compounds have been designed to target and protect the host protein*.
Accordingly, when the virus undergoes minor mutations, Albius’ anti-CoV compounds remain effective. Therefore, Albius’ solutions will work on most kinds of coronaviruses.
(*Conversely, antibodies and vaccines, which rely on precise recognition of specific protein structures, become ineffective as the proteins in each virus undergo minor mutations.)
With this R&D strategy in mind, our scientists have been optimising a lead anti-CoV candidate to treat cats suffering from Feline Infectious Peritonitis (FIP).